OrthoPediatrics currently markets greater than 30 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and more than 40 countries outside the United States.
Investors
Change (%)
Volume
Data as of
Data Provided by Refinitiv. Minimum 15 minutes delayed.
Record Sales Drive Significant Improvement in EBITDA WARSAW, Indiana , Nov. 04, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a Company focused exclusively on advancing the field of pediatric orthopedics, announced today its financial results for
WARSAW, Ind. , Oct. 29, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Mark Throdahl , Chief Executive Officer, Fred Hite , Chief Operating Officer
Conference Call to Discuss Results on November 5, 2020 at 8:00 a.m. ET WARSAW, Ind. , Oct. 21, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that the Company is
